Nadler Financial Group, Inc. Gilead Sciences, Inc. Transaction History

Nadler Financial Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	BUY	$62.32 - $89.47 $164,524 - $236,200	2,640 New	2,640 $226,000
Q1 2022 May 05, 2022	SELL	$57.92 - $72.58 $182,274 - $228,409	-3,147 Closed	0 $0
Q2 2021 Jul 16, 2021	BUY	$63.47 - $69.35 $199,740 - $218,244	3,147 New	3,147 $217,000
Q3 2020 Oct 07, 2020	SELL	$62.1 - $78.08 $167,173 - $210,191	-2,692 Closed	0 $0
Q2 2020 Jul 09, 2020	BUY	$72.34 - $84.0 $194,739 - $226,128	2,692 New	2,692 $207,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Nadler Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Nadler Financial Group, Inc. with notifications on news.